%0 Journal Article
%T Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma.
%A Grant S
%A Meykler S
%A Beach D
%J J Community Support Oncol
%V 12
%N 11
%D Nov 2014
%M 25856014
暂无%R 10.12788/jcso.0088
%X Superior vena cava (SVC) syndrome refers to a constellation of symptoms produced by the obstruction of blood flow through the SVC, resulting in symptoms of dyspnea, facial and upper-extremity edema, cough, chest pain, and dysphagia.1 Malignancies represent 60%-85% of the etiologies of SVC syndrome. Cumulatively, lymphoma and lung cancer represent 95% of malignancy-related SVC syndrome etiologies, with non-small-cell lung cancer (NSCLC) reported in about 50% of cases, small-cell lung cancer (SCLC) in about 25%, and non-Hodgkin lymphoma (NHL) in 10 % of all cases.